The AfricaClinical network currently consists of 243 public hospitals & research Institutes in 20 different African countries with experience in performing clinical trials and clinical research staff. This inludes the following countries:
The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Jimma University is one of the leading higher learning institutions in Ethiopia.
Jimma University functions through integrating teaching, research and community service and well known for its cherished philosophy of Community Based Education, a means of achieving educational relevance to community needs by using community extensively as a learning environment.
RSV GOLD, is the first global registry for young children dying with RSV infection.
The aim is to identify clinical and socioeconomic characteristics of these children. Ultimately, we strive to combat RSV-associated childhood mortality. As RSV presents a global health problem, we have adopted a worldwide approach. Deaths are shared from countries all over the world, making the RSV GOLD project a joint effort by collaborators across the globe. The RSV GOLD project is funded by the Bill and Melinda Gates Foundation.